192 related articles for article (PubMed ID: 7913580)
1. Mutational analysis of patients with neurofibromatosis 2.
MacCollin M; Ramesh V; Jacoby LB; Louis DN; Rubio MP; Pulaski K; Trofatter JA; Short MP; Bove C; Eldridge R
Am J Hum Genet; 1994 Aug; 55(2):314-20. PubMed ID: 7913580
[TBL] [Abstract][Full Text] [Related]
2. CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressor.
MacCollin M
Brain Dev; 1995; 17(4):231-8. PubMed ID: 7503383
[TBL] [Abstract][Full Text] [Related]
3. DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree.
MacCollin M; Mohney T; Trofatter J; Wertelecki W; Ramesh V; Gusella J
JAMA; 1993 Nov; 270(19):2316-20. PubMed ID: 8230593
[TBL] [Abstract][Full Text] [Related]
4. The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts.
Pykett MJ; Murphy M; Harnish PR; George DL
Hum Mol Genet; 1994 Apr; 3(4):559-64. PubMed ID: 8069298
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
[TBL] [Abstract][Full Text] [Related]
6. Exon scanning for mutation of the NF2 gene in schwannomas.
Jacoby LB; MacCollin M; Louis DN; Mohney T; Rubio MP; Pulaski K; Trofatter JA; Kley N; Seizinger B; Ramesh V
Hum Mol Genet; 1994 Mar; 3(3):413-9. PubMed ID: 8012353
[TBL] [Abstract][Full Text] [Related]
7. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.
Jacoby LB; MacCollin M; Parry DM; Kluwe L; Lynch J; Jones D; Gusella JF
Neurogenetics; 1999 Apr; 2(2):101-8. PubMed ID: 10369886
[TBL] [Abstract][Full Text] [Related]
8. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
9. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
Stemmer-Rachamimov AO; Ino Y; Lim ZY; Jacoby LB; MacCollin M; Gusella JF; Ramesh V; Louis DN
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1164-7. PubMed ID: 9862639
[TBL] [Abstract][Full Text] [Related]
10. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
11. Analysis of mutations in the SCH gene in schwannomas.
Bijlsma EK; Merel P; Bosch DA; Westerveld A; Delattre O; Thomas G; Hulsebos TJ
Genes Chromosomes Cancer; 1994 Sep; 11(1):7-14. PubMed ID: 7529050
[TBL] [Abstract][Full Text] [Related]
12. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
13. A G-->A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2.
De Klein A; Riegman PH; Bijlsma EK; Heldoorn A; Muijtjens M; den Bakker MA; Avezaat CJ; Zwarthoff EC
Hum Mol Genet; 1998 Mar; 7(3):393-8. PubMed ID: 9466995
[TBL] [Abstract][Full Text] [Related]
14. A point mutation associated with a severe phenotype of neurofibromatosis 2.
MacCollin M; Braverman N; Viskochil D; Ruttledge M; Davis K; Ojemann R; Gusella J; Parry DM
Ann Neurol; 1996 Sep; 40(3):440-5. PubMed ID: 8797533
[TBL] [Abstract][Full Text] [Related]
15. Highly polymorphic dinucleotide repeat at the NF2 gene.
Bourn D; Strachan T
Hum Genet; 1995 Jun; 95(6):712. PubMed ID: 7789960
[TBL] [Abstract][Full Text] [Related]
16. NF2 gene in neurofibromatosis type 2 patients.
Zucman-Rossi J; Legoix P; Der Sarkissian H; Cheret G; Sor F; Bernardi A; Cazes L; Giraud S; Ollagnon E; Lenoir G; Thomas G
Hum Mol Genet; 1998 Dec; 7(13):2095-101. PubMed ID: 9817927
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations in the neurofibromatosis type 2 tumour suppressor gene.
Bourn D; Carter SA; Mason S; Gareth D; Evans R; Strachan T
Hum Mol Genet; 1994 May; 3(5):813-6. PubMed ID: 8081368
[TBL] [Abstract][Full Text] [Related]
18. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
Bianchi AB; Hara T; Ramesh V; Gao J; Klein-Szanto AJ; Morin F; Menon AG; Trofatter JA; Gusella JF; Seizinger BR
Nat Genet; 1994 Feb; 6(2):185-92. PubMed ID: 8162073
[TBL] [Abstract][Full Text] [Related]
19. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2.
Kluwe L; Mautner VF
Hum Genet; 1996 Feb; 97(2):224-7. PubMed ID: 8566958
[TBL] [Abstract][Full Text] [Related]
20. Detection of novel NF2 mutations by an RNA mismatch cleavage method.
Faudoa R; Xue Z; Lee F; Baser ME; Hung G
Hum Mutat; 2000; 15(5):474-8. PubMed ID: 10790209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]